Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004) [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on the efficacy of pantoprazole in adults with non-erosive reflux disease or gastroesophageal reflux disease (BY1023/DE-004); …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Non-erosive Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Nycomed | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED